SRS offers reasonable tumor control and favorable long-term survival in the adjuvant and salvage setting for patients with residual, recurrent, or metastatic intracranial SFTs. Key prognostic factors included tumor volume, recurrence status, and timing of SRS.
Building similarity graph...
Analyzing shared references across papers
Loading...
Salem M. Tos
Atallah A. Shaaban
Dawood Hamdan
Neuro-Oncology
University of Virginia
University of Alberta
University of Miami
Building similarity graph...
Analyzing shared references across papers
Loading...
Tos et al. (Thu,) studied this question.
www.synapsesocial.com/papers/69a75befc6e9836116a242aa — DOI: https://doi.org/10.1093/neuonc/noag007